QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) | ||
|
||||
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-third of one redeemable warrant to purchase one share of Class A common stock |
||||
share of Class A common stock at an exercise price of $11.50 |
|
|
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller reporting company | |||||
Emerging growth company |
Item 1. |
Financial Statements |
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
Item 4. |
Controls and Procedures |
Page No. |
||||||
Item 1. |
Financial Statements | 1 | ||||
Condensed Balance Sheets | 1 | |||||
Condensed Statements of Operations | 2 | |||||
Condensed Statements of Changes in Stockholders’ Deficit | 3 | |||||
Condensed Statement of Cash Flows | 4 | |||||
Notes to Condensed Financial Statements (As Restated) | 5 | |||||
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations | 16 | ||||
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk | 18 | ||||
Item 4. |
Controls and Procedures (As Restated) | 18 | ||||
19 | ||||||
Item 1. |
Legal Proceedings | 19 | ||||
Item 1A. |
Risk Factors | 19 | ||||
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities | 19 | ||||
Item 3. |
Defaults Upon Senior Securities | 20 | ||||
Item 4. |
Mine Safety Disclosures | 20 | ||||
Item 5. |
Other Information | 20 | ||||
Item 6. |
Exhibits | 20 | ||||
21 |
Item 1. |
Financial Statements |
September 30, 2021 |
December 31, 2020 |
|||||||
(unaudited) |
(auditied) |
|||||||
ASSETS |
||||||||
CURRENT ASSETS |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
Total current assets |
||||||||
NONCURRENT ASSETS |
||||||||
Cash held in trust account |
— | |||||||
Other assets |
— | |||||||
Derivative forward purchase agreement |
— | |||||||
Total noncurrent assets |
— | |||||||
TOTAL ASSETS |
$ | $ | ||||||
LIABILITIES, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS’ DEFICIT |
||||||||
CURRENT LIABILITIES |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued deferred offering costs |
— | |||||||
Franchise tax payable |
— | |||||||
No te payable – related party |
— | |||||||
Total current liabilities |
||||||||
LONG-TERM LIABILITIES |
||||||||
Deferred underwriting commissions |
— | |||||||
Derivative warrant liabilities |
— | |||||||
Total liabilities |
||||||||
Commitments and Contingencies ; |
||||||||
Class A common stock subject to possible redemption shares as of September 30, 2021 and December 31, 2020, respectively, at redemption value of $ |
— | |||||||
STOCKHOLDERS’ DEFICIT |
||||||||
Preferred stock, $ September 30, 2021 and December 31, 2020, respectively |
— | |||||||
Class A common stock, $ shares authorized; (excluding |
— |
|||||||
Class B common stock, $ September 30, 2021 and December 31, 2020, respectively |
||||||||
Additional paid-in capital |
— | |||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total Stockholders’ Deficit |
( |
) | ( |
) | ||||
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT |
$ | |
$ | |
||||
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2021 |
August 31, 2020 (inception) through September 30, 2020 |
||||||||||
OPERATING EXPENSES |
||||||||||||
General and administrative expenses |
$ | $ | $ | |||||||||
Franchise tax expense |
||||||||||||
|
|
|
|
|
|
|||||||
Total operating expenses |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
OTHER INCOME (EXPENSE) |
||||||||||||
Interest income on marketable securities held in Trust Account |
||||||||||||
Underwriting discounts and offering costs attributed to derivative warrant liability |
— | ( |
) | |||||||||
Change in fair value of derivative warrant liabilities |
||||||||||||
Change in fair value of derivative forward purchase agreement |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total other income |
||||||||||||
|
|
|
|
|
|
|||||||
INCOME (LOSS) BEFORE INCOME TAX |
( |
) | ||||||||||
Income tax expense (benefit) |
||||||||||||
|
|
|
|
|
|
|||||||
NET INCOME (LOSS) |
$ | $ | |
$ | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Basic and diluted weighted average shares outstanding, Class A common stock |
||||||||||||
Basic and diluted net income (loss) per share, Class A common stock |
$ | $ | $ | |||||||||
Basic and diluted weighted average shares outstanding, Class B |
||||||||||||
Basic and diluted net income (loss) per share, Class B common stock |
$ | $ | $ | ( |
) |
(1) | The weighted average shares outstanding for the period from August 31, 2020 (inception) through September 30, 2020 excludes an aggregate of up to Class B common stock that was subject to forfeiture if the over-allotment option was exercised in full or in part by the underwriters. The underwriters partially exercised their over-allotment shares on January 29, 2021; therefore the Sponsor forfeited Founder Shares as a result of the partial exercise of the over-allotment shares, while the remaining |
Class B Common Stock |
Additional Paid-in Capital |
(Accumulated Deficit) |
Total Stockholders’ Deficit |
|||||||||||||||||
Shares |
Amount |
|||||||||||||||||||
Balance—December 31, 2020 |
$ |
$ |
$ |
( |
) |
$ |
( |
) | ||||||||||||
Forfeiture of founder shares (2) |
( |
) |
( |
) |
— |
— |
||||||||||||||
Initial classification of derivative forward purchase agreement |
— |
— |
( |
) |
— |
( |
) | |||||||||||||
Accretion of Class A common stock subject to possible redemption |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
( |
) | |
|
( |
) |
Net income |
— |
— |
— |
|||||||||||||||||
Balance—March 31, 2021 |
|
|
|
|
|
|
|
|
|
— |
|
|
|
( |
) | |
|
( |
) | |
Net loss |
— |
— |
— |
( |
) |
( |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance—June 30, 2021 |
— |
( |
) |
( |
) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income |
— |
— |
— |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance—September 30, 2021 |
$ |
$ |
— |
$ |
( |
) |
$ |
( |
) | |||||||||||
|
|
|
|
|
|
|
|
|
|
Additional Paid-in Capital |
(Accumulated Deficit) |
Total Stockholders’ Deficit |
||||||||||||||||||||||||||
Class A Common Stock |
Class B Common Stock |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance—August 31, 2020 (inception) |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||
Issuance of Class B stock to Sponsor (1) |
— |
— |
— |
|||||||||||||||||||||||||
Net income |
— |
— |
— |
— |
— |
( |
) |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance—September 30, 2020 |
— |
$ |
— |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | The Class B common stock includes an aggregate of up to Class B common stock that was subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. |
(2) |
On January 29, 2021 the Sponsor forfeited |
Nine Months Ended September 30, 2021 |
August 31, 2020 (inception) through September 30, 2020 |
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Adjustments to reconcile net income to net cash used in operating activities: |
— | |||||||
Interest earned on cash held in Trust Account |
( |
) | ||||||
Underwriting discounts and transaction costs attributed to warrant liability |
||||||||
Change in fair value of warrant liabilities |
( |
) | ||||||
Change in fair value of derivative forward purchase agreement |
( |
) | ||||||
Changes in operating assets and liabilities: |
— | |||||||
Prepaid expenses |
( |
) | ||||||
Accounts payable |
( |
) | ||||||
Other assets |
( |
) | ||||||
Franchise tax payable |
||||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) | ||||||
|
|
|
|
|||||
CASH FLOWS FROM INVESTING ACTIVITIES |
||||||||
Investment of cash in Trust Account |
( |
) | ||||||
|
|
|
|
|||||
Net cash used in investing activities |
( |
) | ||||||
|
|
|
|
|||||
CASH FLOW FROM FINANCING ACTIVITIES |
||||||||
Proceeds from sale of Units, net of underwriting discounts paid |
||||||||
Proceeds from sale of Private Placement Warrants |
||||||||
Proceeds from sale of Class B common stock |
— | |||||||
Proceeds from issuance of note payable – related party |
— | |||||||
Repayment of note payable – related party |
( |
) | ||||||
Payment of offering costs |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net cash provided by financing activities |
||||||||
|
|
|
|
|||||
NET CHANGE IN CASH |
||||||||
CASH, BEGINNING OF PERIOD |
||||||||
|
|
|
|
|||||
CASH, END OF PERIOD |
$ | $ | ||||||
|
|
|
|
|||||
SUPPLEMENTAL DISCLOSURES OF NONCASH ACTIVITIES |
||||||||
Initial classification of derivative warrant liability |
$ | $ | ||||||
Initial classification of derivative forward purchase agreement |
$ | ( |
) | $ | ||||
Initial value of common stock subject to possible redemption, as revised |
$ | $ | ||||||
Deferred underwriting fees charged to additional paid in capital |
$ | $ | ||||||
Deferred offering costs included in accrued deferred offering costs |
$ | $ |
Fair Value Measurement as of September 30, 2021 |
||||||||||||
Level 1 |
Level 2 |
Level 3 |
||||||||||
Assets: |
||||||||||||
Investments held in trust account (1) |
$ | |
$ | — | $ | — | ||||||
Derivative forward purchase agreements (2) |
$ | — | $ | — | $ | |||||||
Liabilities: |
||||||||||||
Derivative warrant liabilities—Public Warrants (3) |
$ | $ | — | $ | — | |||||||
Derivative warrant liabilities—Private Placement Warrants (4) |
$ | — | $ | — | $ |
(1) |
The fair value of the investments held in Trust Account was based on the quoted market price. |
(2) |
The fair value of the derivative forward purchase agreement was based on the forward price formula. |
(3) |
The fair value of the derivative warrant liabilities – Public Warrants was based the quoted market price for MIT.W as of the reporting date. |
(4) |
The fair value of the derivative warrant liabilities – Private Placement Warrants was based on a modified Black-Scholes model. |
February 2, 2021 (Initial Measurement) |
||||
Strike price |
$ |
|||
Term (in years) |
||||
Risk-free rate |
% | |||
Volatility |
% | |||
Dividend yield |
% | |||
Fair value of Public Warrants |
$ |
|||
Fair value of Private Placement Warrants |
$ |
September 30, 2021 |
||||
Strike price |
$ |
|||
Term (in years) |
||||
Risk-free rate |
% | |||
Volatility |
% | |||
Dividend yield |
% | |||
Fair value of Private Placement Warrants |
$ |
• | Term – the expected life of the warrants was assumed to be equivalent to their remaining contractual term. |
• | Risk-free rate – the risk-free interest rate is based on the U.S. Treasury yield curve in effect on the date of valuation equal to the remaining expected life of the Warrants. |
• | Volatility – the Company estimated the volatility of its common stock warrants based on implied volatility and actual historical volatility of a group of comparable publicly traded companies observed over a historical period equal to the expected remaining life of the Warrants. |
• | Dividend yield – the dividend yield percentage is zero because the Company does not currently pay dividends, nor does it intend to do so during the expected term of the Private Placement Warrants. |
Public Warrants |
Private Warrants |
Total Derivative Warrants Liability |
||||||||||
Derivative warrant liabilities at January 1, 2021 |
$ | $ | $ | |||||||||
Issuance of Public and Private Warrants (1) |
||||||||||||
Change in fair value of warrant liabilities |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Derivative warrant liabilities at March 31, 2021 |
$ | $ | $ | |||||||||
Change in fair value of warrant liabilities |
||||||||||||
|
|
|
|
|
|
|||||||
Derivative warrant liabilities at June 30, 2021 |
$ | $ | $ | |||||||||
Change in fair value of warrant liabilities |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Derivative warrant liabilities at September 30, 2021 |
$ | $ | $ | |||||||||
|
|
|
|
|
|
(1) | – During the 1 st quarter of 2021, these warrants were transferred from Level 3 in the fair value hierarchy to Level 1 in the fair value hierarchy |
FPA Asset (Liability) |
||||
Derivative forward purchase agreement at January 1, 2021 |
$ | |||
Executed forward purchase agreement in connection with IPO |
( |
) | ||
Change in fair value of the derivative forward purchase agreement |
||||
|
|
|||
Derivative forward purchase agreement at March 31, 2021 |
$ |
|||
Change in fair value of the derivative forward purchase agreement |
||||
Derivative forward purchase agreement at June 30, 2021 |
$ |
|||
Change in fair value of the derivative forward purchase agreement |
( |
) | ||
|
|
|||
Derivative forward purchase agreement at September 30, 2021 |
$ | |||
|
|
• | in whole and not in part; |
• | at a price of $ |
• | at any time during the exercise period; |
• | upon a minimum of |
• | if, and only if, the last sale price of the Company’s Class A common stock equals or exceeds $ |
• | If, and only if, there is a current registration statement in effect with respect to the shares of Class A common stock underlying such warrants. |
Three Months Ended |
Nine Months Ended |
August 31, 2020 (inception) through |
||||||||||||||||||||||
September 30, 2021 |
September 30, 2021 |
September 30, 2020 |
||||||||||||||||||||||
Class A |
Class B |
Class A |
Class B |
Class A |
Class B |
|||||||||||||||||||
Basic and diluted net loss per share |
||||||||||||||||||||||||
Numerator |
||||||||||||||||||||||||
Allocation of net income |
$ |
$ |
$ |
$ |
$ |
— |
$ |
( |
) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Denominator |
||||||||||||||||||||||||
Weighted-average shares outstanding (1) |
— |
|||||||||||||||||||||||
Basic and diluted net income per share |
$ |
$ |
$ |
$ |
$ |
— | $ |
( |
) |
(1) |
The weighted average shares outstanding for the period from August 31, 2020 (inception) through September 30, 2020 excludes an aggregate of up to |
Gross Proceeds |
$ |
|||
Less: |
||||
Offering costs and underwriting fees allocated to Class A common stock subject to possible redemption |
( |
) | ||
Proceeds allocated to Public Warrants at issuance |
( |
) | ||
Plus: |
||||
Accretion on Class A common stock subject to possible redemption amount |
||||
|
|
|||
Class A common stock subject to possible redemption |
$ |
|||
|
|
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk |
Item 4. |
Controls and Procedures |
Item 1. |
Legal Proceedings |
Item 1A. |
Risk Factors. |
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds |
Item 3. |
Defaults Upon Senior Securities |
Item 4. |
Mine Safety Disclosures |
Item 5. |
Other Information |
Item 6. |
Exhibits. |
* | Filed herewith. |
** | Furnished. |
MASON INDUSTRIAL TECHNOLOGY, INC. | ||||||
Date: December 8, 2021 | By: | /s/ Derek Satzinger | ||||
Name: | Derek Satzinger | |||||
Title: | Chief Financial Officer |